No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
AdAlta Ltd: Half Yearly Report and Accounts
AdAlta Ltd. Announces Quotation of New Securities on ASX
AdAlta Quits Internal R&D Work for Antifibrotic Drug as Cellular Immunotherapy Strategy Gains Focus; Shares Fall 6%
AdAlta Ltd. Issues Performance Rights to Boost Talent Retention
AdAlta Ltd. Showcases Drug Development Prospects
AdAlta Ltd. Sees Shift in Major Shareholding